Bananas are brain food.....maybe you should try some
reprofiled drug which has previously passed Phase 1 for another indication this together with the recent announcement on programme and attraction of new 'sophisticated' investors in recent capital raise would indicate to me it is extremely unlikely Phase 1 is going to fail.
The current valuation only reflects the value of growing profitable services business which incidentally provides cashflow to support the trial costs
- Forums
- ASX - By Stock
- NDL
- research
research , page-7
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)